Utama › Karsinoma Sel Merkel
Kajian klinikal Karsinoma Sel Merkel sedang mengambil peserta di AS
24 kajian untuk Karsinoma Sel Merkel sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX6 kajian
- Boston, MA5 kajian
- Tampa, FL4 kajian
- New York City, NY4 kajian
- San Antonio, TX4 kajian
- Seattle, WA3 kajian
- Queens, NY3 kajian
- Jacksonville, FL3 kajian
- Miami, FL3 kajian
- Pittsburgh, PA3 kajian
- Arlington, VA3 kajian
- Los Angeles, CA3 kajian
- St. Louis, MO3 kajian
- Washington, DC3 kajian
- Nashville, TN3 kajian
Mengikut negeri
- California5 kajian
- Florida11 kajian
- Maryland3 kajian
- Massachusetts5 kajian
- Michigan5 kajian
- Missouri3 kajian
- New Jersey3 kajian
- New York4 kajian
- North Carolina3 kajian
- Pennsylvania4 kajian
- Tennessee3 kajian
- Texas8 kajian
- Virginia3 kajian
- Washington4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05583708Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Mengambil pesertaFasa 1
Umur 18 hingga 100 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07006727Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Mengambil pesertaFasa 1/2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06814496Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 100 Years · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02471352A Study of CRD3874-SI in People With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06021626Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05267626Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 4 Sep 2026 · NCT02479698Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05896839Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 16 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05269381A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07115043A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT05859074A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07749586Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT05100095Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT04975152MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05076760Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT06947928EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
Mengambil pesertaFasa 2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT06223659Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT05496036TIL Therapy in cSCC and MCC
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT07288073IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Okt 2025 · NCT06940440A Beta-only IL-2 ImmunoTherapY Study
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2025 · NCT05086692Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.